Stay updated with breaking news from Ron Weitzman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Once every 3-week dosing of SNS-101 demonstrates initial signs of promising clinical activity - - Pharmacokinetic and safety profi
Conditionally Active Antibodies for Immuno-oncology Corporate Deck | April 2024 Disclaimer This...
Imugene Ltd (ASX:IMU, OTC:IUGNF) has appointed two-decade veteran Dr Ron Weitzman as its interim chief medical officer, replacing Dr Giovanni Selvaggi. Dr...
The local share market is likely to open higher today, with futures up 0.6% this morning following a solid day’s trade on Wall Street. The Australian dollar...
- Fast Track Designation granted to TNG462, next-generation MTA-Cooperative PRMT5 inhibitor - - Adam Crystal, M.D., Ph.D. appointed President of Research and Development - BOSTON, March 27, 2023 (GLOBE